Medicine for treating bovine tinea and preparation method thereof

By combining the plaster of traditional Chinese medicine ingredients with the carrier to form a drug patch, combined with oral and external application, the existing problems of traditional Chinese medicine dosage control and side effects of psoriasis treatment have been solved, and the treatment effect is improved and safety is guaranteed.

CN118903205AInactive Publication Date: 2024-11-08沈军
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411337501.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-25
Publication Date
2024-11-08
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure CN118903205A_ABST
    Figure CN118903205A_ABST
Patent Text Reader

Abstract

The invention discloses a medicine for treating bovine tinea and a preparation method thereof, the medicine comprises a plaster and a carrier, and the carrier is used for carrying the plaster and is fixed on an affected part; the plaster comprises medicinal materials and a matrix, and the medicinal materials have active ingredients for treating psoriasis and at least comprise wide-angle powder and cortex dictamni; the substrate is a carrier of the medicinal materials and is used for fixing the medicinal materials on affected parts and promoting absorption of the medicinal materials; the medicinal materials are divided into an oral medicine part and an external application medicine part; the oral medicine comprises wide-angle powder. The medicine provided by the invention has the effects of cooling blood, clearing heat, detoxifying and dispelling wind, is suitable for patients with syndromes of acute progressive psoriasis, exfoliative dermatitis (acute stage), acra red pain, erysipelas, cellulitis and the like, integrally adopts traditional Chinese medicine components, the effective components are not easy to lose, the medicine can be stored for a long time, the side effect is small, and the medicine harm to a human body is reduced; the treatment mode of combining oral administration and external application is good in treatment effect and quick in effect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of drugs for treating skin diseases, in particular to a drug for treating psoriasis and a preparation method thereof. Background Art

[0002] Psoriasis, also known as psoriasis, is a common chronic skin disease, mainly manifested by the appearance of red patches on the skin. These patches may be round or oval, of varying sizes, with clear borders, and covered with silvery white or grayish white scales. The shedding of scales may cause local bleeding. Patients may experience itching, especially in dry or low temperature seasons. Certain lesions may also cause pain or burning sensations, which not only affects the patient's appearance, but may also bring discomfort such as itching and pain, significantly affecting the patient's quality of life and mental health.

[0003] Currently, there are various treatments for psoriasis, including local treatment, systemic treatment, psychotherapy and lifestyle adjustment, among which local treatment usually adopts topical drugs such as glucocorticoids, retinoic acid drugs, vitamin D3 derivatives, etc., and phototherapy such as ultraviolet irradiation, etc. However, in the clinical treatment of psoriasis, it is found that the treatment method of applying topical drugs has the disadvantages of difficult control of dosage, easy cross-contamination of drugs, difficult preservation, and large side effects of drugs. Therefore, the present application proposes a drug for treating psoriasis and a preparation method thereof. Summary of the invention

[0004] The purpose of the present invention is to provide a medicine for treating psoriasis and a preparation method thereof. The medicine has the effects of cooling blood, clearing heat, detoxifying and expelling wind, and is suitable for patients with symptoms such as acute progressive psoriasis, exfoliative dermatitis (acute stage), acrodynia, erysipelas, cellulitis, etc. The medicine adopts Chinese medicinal ingredients as a whole, and the effective ingredients are not easy to be lost. The dosage is fixed, the medicine can be stored for a long time, it is not easy to be cross-contaminated, and the side effects are small, thereby reducing the harm of the medicine to the human body. The treatment method of combining oral administration with external application has good treatment effect and quick effect.

[0005] To achieve the above object, the present invention provides the following technical solutions:

[0006] A medicine for treating psoriasis, comprising a plaster and a carrier, wherein the carrier is used to carry the plaster and fix it on an affected area;

[0007] The plaster comprises medicinal materials and a matrix, wherein the medicinal materials have active ingredients for treating psoriasis, and at least include radix galangae and cortex dichamati; the matrix is ​​a carrier of the medicinal materials, and is used to fix the medicinal materials on the affected area and promote the absorption of the medicinal materials;

[0008] Preferably, the medicinal materials are divided into oral dosage and external application dosage;

[0009] The oral dosage includes wide angle powder;

[0010] The external application ingredients include: raw rehmannia, Scrophularia, Ophiopogon, Cortex Moutan, White Peony Root, Flos Lonicerae, Baical Scutellariae, Gardenia, Cortex Dictamni and Smilax glabra.

[0011] Preferably, the composition ratio of the medicinal materials is:

[0012] 0.5 parts of iris root, 15 parts of radix rehmanniae, 7.5 parts of rhizoma scrophulariae, 5 parts of ophiopogon, 5 parts of cortex moutan, 7.5 parts of white peony root, 15 parts of flos honeysuckle, 7.5 parts of baicalin, 5 parts of gardenia, 16 parts of cortex divaricatae, 16 parts of rhizoma smilax.

[0013] Preferably, the carrier has an adhesive surface that is in direct contact with the skin and an appearance surface that faces away from the skin. The external application portion of the medicinal material is mixed with the matrix and then coated on the adhesive surface of the carrier, and the oral portion of the medicinal material is independently encapsulated in wide-angle powder on the appearance surface of the carrier.

[0014] Preferably, the mixing ratio of the external application portion of the medicinal material to the matrix is ​​1:3.

[0015] Preferably, the carrier includes a backing layer and an anti-sticking layer, one side of the backing layer is an appearance surface, and the other side is an adhesive surface for coating the external application drug portion of the medicinal material and the matrix mixture, and the anti-sticking layer is applied to the adhesive surface of the backing layer coated with the external application drug portion of the medicinal material and the matrix mixture.

[0016] Preferably, the backing layer material is non-woven fabric, and the anti-sticking layer material is anti-sticking paper.

[0017] Preferably, the adhesive surface of the backing layer is adhered with an adhesive surrounding the external application portion of the medicinal material and the matrix mixture, and the adhesive is selected from one of polyacrylate and polyurethane. The appearance surface of the backing layer is provided with a packaging bag for packaging the oral portion of the medicinal material, and an easy-tear opening is opened on one side of the packaging bag.

[0018] Preferably, the components of the matrix are an oil phase, an aqueous phase, an emulsifier and a volatile agent, and the component ratio is: 20 parts of the oil phase, 70 parts of the aqueous phase, 5 parts of the emulsifier, and 5 parts of the volatile agent.

[0019] A method for preparing a medicine for treating psoriasis, comprising the following steps:

[0020] Step 1: Prepare the carrier, prepare non-woven fabric, anti-sticking paper, aluminum foil packaging film, polyacrylate or polyurethane, cut the non-woven fabric into small pieces of equal size, the cutting length size range is: 5 to 8 cm, the cutting width size range is: 3 to 6 cm, use aluminum foil packaging film to make a packaging bag on one side of the cut non-woven fabric, and coat the other side of the cut non-woven fabric with polyacrylate or polyurethane, leaving a circular reserved space in the middle;

[0021] Step 2: Preparation of herbs:

[0022] Preparation of oral dosage: take 5% of the wide-angle powder, put it into a packaging bag on a non-woven fabric and seal it, and open an easy-tear opening on one side of the packaging bag;

[0023] Preparation of external application medicine: 15% of Radix Rehmanniae, 7.5% of Scrophulariae, 5% of Radix Ophiopogonis, 5% of Cortex Moutan, 7.5% of Radix Paeoniae Alba, 15% of Flos Lonicerae, 7.5% of Radix Scutellariae, 5% of Fructus Gardeniae, 16% of Cortex Dictamni, 16% of Rhizoma Smilacis Glabrae, mix well and grind into powder to obtain external application medicine mixed powder;

[0024] Step 3: Matrix preparation: take 20% of the oil phase, 70% of the water phase, 5% of the emulsifier, and 5% of the volatile agent, place the oil phase in a container and heat it to a molten state, and at the same time, heat the water phase components (such as distilled water, glycerin, etc.) to an appropriate temperature, slowly add the water phase to the oil phase under stirring conditions, add the emulsifier and stir continuously, add the volatile agent and stir for several seconds after forming a uniform emulsion, and obtain an emulsion or gel-like matrix, wherein the oil phase is selected from one of stearic acid, glyceryl monostearate, and white vaseline, the water phase is selected from one of distilled water and glycerin, the emulsifier is triethanolamine, and the volatile agent is selected from a diluent of peppermint essential oil diluted 10 times, and the stirring speed range is 200-400r / min;

[0025] Step 4: Preparation of plaster: Disperse the mixed powder of the external application drug prepared in step 2 and add it into the gelatinous matrix prepared in step 3, and continue to stir evenly to obtain an external application ointment;

[0026] Step 5: Packaging the ointment, evenly apply the ointment prepared in step 4 to the circular reserved space reserved by the non-woven fabric, and attach the anti-adhesive paper to the side of the non-woven fabric coated with the ointment to obtain a plaster for treating psoriasis;

[0027] Step 6: cutting and packaging, cutting the prepared medicine patch and packaging it in an aluminum foil packaging bag to obtain a finished medicine patch for treating psoriasis;

[0028] Step 7: Quality inspection and storage. The finished products of the plaster for treating psoriasis are quality inspected. The quality inspection items at least include the inspection of size, packaging sealing, and the amount of oral and topical medicine. The finished products of the plaster that pass the quality inspection are put into storage.

[0029] Compared with the prior art, the present invention has the following beneficial effects:

[0030] The invention adopts the Chinese medicine formula. The wide-angle powder has the effects of clearing away heat and calming the nerves, cooling blood and detoxifying, and is used for symptoms of warm-heat toxicity and macules on the body. The white mulberry bark has the effects of clearing heat and drying dampness, dispelling wind and detoxifying, and is used to treat symptoms of damp-heat sores, yellow water dripping, eczema, rubella, scabies, rheumatic heat arthralgia, jaundice, red urine and the like. The invention is combined with raw rehmannia, scrophularia, ophiopogon, moutan bark, white peony root, honeysuckle, scutellaria, gardenia and smilax glabra, and the whole has the effects of cooling blood and clearing heat, detoxifying and dispelling wind. The invention is suitable for patients with symptoms such as acute progressive psoriasis, exfoliative dermatitis (acute stage), acroerythritis, erysipelas, cellulitis and the like. The whole adopts Chinese medicine ingredients, the effective ingredients are not easy to be lost, the medicine amount is fixed, the medicine can be stored for a long time, it is not easy to be cross-contaminated, the side effect is small, and the drug harm to human body is reduced. The mint essence diluent added in the matrix can be carried, and the medicine portion can be quickly volatilized and applied to the affected part, so the effect is quick and the therapeutic effect is good.

[0031] The present invention divides the medicinal materials into oral medicine and external application medicine, and the external application medicine is made into a medicine patch for external application, which is simple to operate and easy to operate for treatment, and can shield the affected area to prevent the affected skin from affecting the patient's normal life. In addition, the treatment method combining oral administration and external application has better treatment effect and faster effect.

[0032] Of course, any product implementing the present invention does not necessarily need to achieve all of the advantages described above at the same time. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] Figure 1 It is a structural block diagram of the drug for treating psoriasis of the present invention;

[0034] Figure 2 It is a structural block diagram of the plaster of the present invention;

[0035] Figure 3 is a flow chart of the method of the present invention;

[0036] Figure 4 The figure is a schematic diagram of the structure of the medicine patch for treating psoriasis of the present invention. DETAILED DESCRIPTION

[0037] In the description of the present invention, it should be understood that the terms "length", "width", "up", "down", "front", "back", "left", "right", "vertical", "horizontal", "top", "bottom", "inside", "outside" and the like indicate positions or positional relationships based on the positions or positional relationships shown in the drawings, and are only for the convenience of describing the present invention and simplifying the description, rather than indicating or implying that the device or element referred to must have a specific position, be constructed and operated in a specific position, and therefore cannot be understood as limiting the present invention. The following describes various embodiments of the present invention in detail in conjunction with the drawings.

[0038] Example

[0039] See also Figures 1 to 4 , the present invention preferably provides a technical solution:

[0040] A medicine for treating psoriasis, comprising a plaster and a carrier, wherein the carrier is used to carry the plaster and fix it on an affected area;

[0041] The plaster comprises: medicinal materials and a matrix, wherein the medicinal materials have active ingredients for treating psoriasis, and at least include galangal powder and white mulberry bark; the matrix is ​​a carrier of the medicinal materials, and is used to fix the medicinal materials on the affected area and promote the absorption of the medicinal materials;

[0042] The medicinal materials are divided into oral medicines and external application medicines; the oral medicines include wide-angle powder; the external application medicines include: raw rehmannia, scrophularia, ophiopogon, moutan bark, white peony root, honeysuckle, scutellaria, gardenia, white smilax glabra and wild yam.

[0043] Specifically, the proportion of medicinal materials is: 0.5 parts of iris powder, 15 parts of raw rehmannia, 7.5 parts of Scrophularia, 5 parts of Ophiopogon, 5 parts of Moutan, 7.5 parts of White Peony, 15 parts of Lonicera, 7.5 parts of Scutellaria, 5 parts of Gardenia, 16 parts of Dictamni, and 16 parts of Smilax glabra.

[0044] In the above-mentioned medicinal material formula, Guangjiao powder has the effects of clearing away heat and calming the nerves, cooling blood and detoxifying, and is used for symptoms of warm and toxic excess and body rashes. Dictamni has the effects of clearing away heat and dampness, dispelling wind and detoxifying, and is used to treat damp-heat sores, yellow water dripping, eczema, rubella, scabies, rheumatic heat arthralgia, jaundice and red urine and other symptoms. It is combined with Radix Rehmanniae, Scrophulariae, Ophiopogon japonicus, Cortex Moutan, White Peony Root, Flos Lonicerae, Scutellariae Baicalensis, Gardenia Jasminoides and Smilax glabra, and the whole adopts traditional Chinese medicine ingredients. The effective ingredients are not easy to dissipate, the dosage is fixed, it can be stored for a long time, it is not easy to be cross-contaminated, the side effects are small, and the drug harm to the human body is reduced. In addition, the treatment method combining oral and external application has better therapeutic effect and faster effect.

[0045] The carrier has an adhesive surface that is in direct contact with the skin and an appearance surface that faces away from the skin. The external application drug portion of the medicinal material is mixed with a matrix and then coated on the adhesive surface of the carrier. The oral drug portion of the medicinal material, wide-angle powder, is independently encapsulated on the appearance surface of the carrier. The mixing ratio of the external application drug portion of the medicinal material and the matrix is ​​1:3. This mixing ratio not only ensures the therapeutic effect of the external application drug portion on psoriasis, but also ensures that the ointment can adhere to the affected area.

[0046] The carrier includes a backing layer and an anti-sticking layer. One side of the backing layer is an appearance surface, and the other side is an adhesive surface, which is used to coat the external application drug portion of the medicinal material and the matrix mixture. The anti-sticking layer is applied to the adhesive surface of the backing layer coated with the external application drug portion of the medicinal material and the matrix mixture.

[0047] The backing layer material is non-woven fabric, and the anti-adhesive layer material is anti-adhesive paper.

[0048] The adhesive surface of the backing layer is adhered with an adhesive surrounding the external application medicine portion of the medicinal material and the matrix mixture. The adhesive is selected from one of polyacrylate and polyurethane. The appearance surface of the backing layer is provided with a packaging bag for packaging the oral medicine portion of the medicinal material. An easy-tear opening is opened on one side of the packaging bag for packaging the oral medicine portion wide-angle powder. When the medicine is used, the wide-angle powder in the packaging bag is poured out and taken orally, and then the backing layer and the remaining ointments can be applied to the affected area for treatment.

[0049] The components of the matrix are an oil phase, an aqueous phase, an emulsifier and a volatile agent, and the component ratio is: 20 parts of the oil phase, 70 parts of the aqueous phase, 5 parts of the emulsifier, and 5 parts of the volatile agent.

[0050] A method for preparing a medicine for treating psoriasis, comprising the following steps:

[0051] Step 1: Prepare the carrier, prepare non-woven fabric, anti-sticking paper, aluminum foil packaging film, polyacrylate or polyurethane, cut the non-woven fabric into small pieces of equal size, the cutting length size range is: 5 to 8 cm, the cutting width size range is: 3 to 6 cm, use aluminum foil packaging film to make a packaging bag on one side of the cut non-woven fabric, and coat the other side of the cut non-woven fabric with polyacrylate or polyurethane, leaving a circular reserved space in the middle;

[0052] Step 2: Preparation of herbs:

[0053] Preparation of oral dosage: take 5% of the wide-angle powder, put it into a packaging bag on a non-woven fabric and seal it, and open an easy-tear opening on one side of the packaging bag;

[0054] Preparation of external application medicine: 15% of Radix Rehmanniae, 7.5% of Scrophulariae, 5% of Radix Ophiopogonis, 5% of Cortex Moutan, 7.5% of Radix Paeoniae Alba, 15% of Flos Lonicerae, 7.5% of Radix Scutellariae, 5% of Fructus Gardeniae, 16% of Cortex Dictamni, 16% of Rhizoma Smilacis Glabrae, mix well and grind into powder to obtain external application medicine mixed powder;

[0055] Step 3: Matrix preparation: take 20% of the oil phase, 70% of the water phase, 5% of the emulsifier, and 5% of the volatile agent, place the oil phase in a container and heat it to a molten state, and at the same time, heat the water phase components (such as distilled water, glycerin, etc.) to an appropriate temperature, slowly add the water phase to the oil phase under stirring conditions, add the emulsifier and stir continuously, add the volatile agent and stir for several seconds after forming a uniform emulsion, and obtain an emulsion or gel-like matrix, wherein the oil phase is selected from one of stearic acid, glyceryl monostearate, and white vaseline, the water phase is selected from one of distilled water and glycerin, the emulsifier is triethanolamine, and the volatile agent is selected from a diluent of peppermint essential oil diluted 10 times, and the stirring speed range is 200-400r / min;

[0056] Step 4: Preparation of plaster: Disperse the mixed powder of the external application drug prepared in step 2 and add it into the gelatinous matrix prepared in step 3, and continue to stir evenly to obtain an external application ointment;

[0057] Step 5: Packaging the ointment, evenly apply the ointment prepared in step 4 to the circular reserved space reserved by the non-woven fabric, and attach the anti-adhesive paper to the side of the non-woven fabric coated with the ointment to obtain a plaster for treating psoriasis;

[0058] Step 6: cutting and packaging, cutting the prepared medicine patch and packaging it in an aluminum foil packaging bag to obtain a finished medicine patch for treating psoriasis;

[0059] Step 7: Quality inspection and storage. The finished products of the plaster for treating psoriasis are quality inspected. The quality inspection items at least include the inspection of size, packaging sealing, and the amount of oral and topical medicine. The finished products of the plaster that pass the quality inspection are put into storage.

[0060] The invention adopts the Chinese medicine formula. The wide-angle powder has the effects of clearing away heat and calming the nerves, cooling blood and detoxifying, and is used for symptoms of warm-heat toxicity and macules on the body. The white mulberry bark has the effects of clearing heat and drying dampness, dispelling wind and detoxifying, and is used to treat symptoms of damp-heat sores, yellow water dripping, eczema, rubella, scabies, rheumatic heat arthralgia, jaundice, red urine and the like. The invention is combined with raw rehmannia, scrophularia, ophiopogon, moutan bark, white peony root, honeysuckle, scutellaria, gardenia and smilax glabra, and the whole has the effects of cooling blood and clearing heat, detoxifying and dispelling wind. The invention is suitable for patients with symptoms such as acute progressive psoriasis, exfoliative dermatitis (acute stage), acroerythritis, erysipelas, cellulitis and the like. The whole adopts Chinese medicine ingredients, the effective ingredients are not easy to be lost, the medicine amount is fixed, the medicine can be stored for a long time, it is not easy to be cross-contaminated, the side effect is small, and the drug harm to human body is reduced. The mint essence diluent added in the matrix can be carried, and the medicine portion can be quickly volatilized and applied to the affected part, so the effect is quick and the therapeutic effect is good. By dividing the medicinal materials into oral portions and external application portions, the external application portions are made into external application patches, which are simple to operate and easy to treat, and can cover the affected area to prevent the affected skin from affecting the patient's normal life. In addition, the combination of oral and external application treatment has better therapeutic effects and faster results.

[0061] In the present invention, unless otherwise clearly specified and limited, the terms "install", "connect", "connect", "fix" and the like should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection or an indirect connection through an intermediate medium, it can be the internal connection of two elements or the interaction relationship between two elements. There are many ways of detachable installation, for example, it can be through the method of plug-in and snap-on matching, and for example, through the method of bolt connection, etc.

[0062] The above clearly and completely describes the concept, specific structure and technical effects of the present invention in combination with the embodiments and drawings, so as to fully understand the purpose, characteristics and effects of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, other embodiments obtained by technicians in this field without creative work are all within the scope of protection of the present invention. In addition, all the connection / connection relationships mentioned in the text do not refer to the direct connection of components, but refer to the fact that a better connection structure can be formed by adding or reducing connection accessories according to the specific implementation situation.

[0063] The specific description of the present invention in the above embodiments is only used to further illustrate the present invention and cannot be understood as limiting the scope of protection of the present invention. Technical engineers in this field may make some non-essential improvements and adjustments to the present invention based on the contents of the above invention, which fall within the scope of protection of the present invention.

Claims

1. A drug for treating psoriasis, characterized in that: include: Plaster and carrier, the carrier is used to carry the plaster and fix it on the affected area; The plaster comprises: Medicinal materials, having active ingredients for treating psoriasis, including at least Psoralea corylifolia and Dictamni; The matrix is ​​the carrier of the medicinal materials, which is used to fix the medicinal materials on the affected area and promote the absorption of the medicinal materials.

2. A drug for treating psoriasis according to claim 1, characterized in that: The medicinal materials are divided into oral dosage and external application dosage; The oral dosage includes wide angle powder; The external application ingredients include: raw rehmannia, Scrophularia, Ophiopogon, Cortex Moutan, White Peony Root, Flos Lonicerae, Baical Scutellariae, Gardenia, Cortex Dictamni and Smilax glabra.

3. A drug for treating psoriasis according to claim 2, characterized in that: The composition ratio of the medicinal materials is: 0.5 parts of iris root, 15 parts of radix rehmanniae, 7.5 parts of rhizoma scrophulariae, 5 parts of ophiopogon, 5 parts of cortex moutan, 7.5 parts of white peony root, 15 parts of flos honeysuckle, 7.5 parts of baicalin, 5 parts of gardenia, 16 parts of cortex divaricatae, 16 parts of rhizoma smilax.

4. A drug for treating psoriasis according to claim 2, characterized in that: The carrier has an adhesive surface that is in direct contact with the skin and an appearance surface that faces away from the skin. The external application portion of the medicinal material is mixed with a matrix and coated on the adhesive surface of the carrier, and the oral portion of the medicinal material, a wide-angle powder, is independently encapsulated on the appearance surface of the carrier.

5. A drug for treating psoriasis according to claim 4, characterized in that: The mixing ratio of the external application portion of the medicinal material to the matrix is ​​1:

3.

6. A drug for treating psoriasis according to claim 1, characterized in that: The carrier includes a backing layer and an anti-sticking layer. One side of the backing layer is an appearance surface, and the other side is an adhesive surface for coating the external application drug portion of the medicinal material and the matrix mixture. The anti-sticking layer is applied to the adhesive surface of the backing layer coated with the external application drug portion of the medicinal material and the matrix mixture.

7. A drug for treating psoriasis according to claim 6, characterized in that: The backing layer material is non-woven fabric, and the anti-sticking layer material is anti-sticking paper.

8. A drug for treating psoriasis according to claim 6, characterized in that: The adhesive surface of the backing layer is adhered with an adhesive surrounding the external application portion of the medicinal material and the matrix mixture, and the adhesive is selected from one of polyacrylate and polyurethane. The appearance surface of the backing layer is provided with a packaging bag for packaging the oral portion of the medicinal material, and an easy-tear opening is opened on one side of the packaging bag.

9. A drug for treating psoriasis according to claim 8, characterized in that: The components of the matrix are an oil phase, an aqueous phase, an emulsifier and a volatile agent, and the component ratio is: 20 parts of the oil phase, 70 parts of the aqueous phase, 5 parts of the emulsifier, and 5 parts of the volatile agent.

10. A method for preparing a drug for treating psoriasis, applicable to the drug for treating psoriasis according to any one of claims 1 to 9, characterized in that: The following steps are involved: Step 1: Prepare the carrier, prepare non-woven fabric, anti-sticking paper, aluminum foil packaging film, polyacrylate or polyurethane, cut the non-woven fabric into small pieces of equal size, the cutting length size range is: 5 to 8 cm, the cutting width size range is: 3 to 6 cm, use aluminum foil packaging film to make a packaging bag on one side of the cut non-woven fabric, and coat the other side of the cut non-woven fabric with polyacrylate or polyurethane, leaving a circular reserved space in the middle; Step 2: Preparation of herbs: Preparation of oral dosage: take 5% of the wide-angle powder, put it into a packaging bag on a non-woven fabric and seal it, and open an easy-tear opening on one side of the packaging bag; Preparation of external application medicine: 15% of Radix Rehmanniae, 7.5% of Scrophulariae, 5% of Radix Ophiopogonis, 5% of Cortex Moutan, 7.5% of Radix Paeoniae Alba, 15% of Flos Lonicerae, 7.5% of Radix Scutellariae, 5% of Fructus Gardeniae, 16% of Cortex Dictamni, 16% of Rhizoma Smilacis Glabrae, mix well and grind into powder to obtain external application medicine mixed powder; Step 3: Matrix preparation: take 20% of the oil phase, 70% of the water phase, 5% of the emulsifier, and 5% of the volatile agent, place the oil phase in a container and heat it to a molten state, and at the same time, heat the water phase components (such as distilled water, glycerin, etc.) to an appropriate temperature, slowly add the water phase to the oil phase under stirring conditions, add the emulsifier and stir continuously, add the volatile agent and stir for several seconds after forming a uniform emulsion, and obtain an emulsion or gel-like matrix, wherein the oil phase is selected from one of stearic acid, glyceryl monostearate, and white vaseline, the water phase is selected from one of distilled water and glycerin, the emulsifier is triethanolamine, and the volatile agent is selected from a diluent of peppermint essential oil diluted 10 times, and the stirring speed range is 200-400r / min; Step 4: Preparation of plaster: Disperse the mixed powder of the external application drug prepared in step 2 and add it into the gelatinous matrix prepared in step 3, and continue to stir evenly to obtain an external application ointment; Step 5: Packaging the ointment, applying the ointment prepared in step 4 evenly to the circular reserved space reserved by the non-woven fabric, and attaching the anti-adhesive paper to the side of the non-woven fabric coated with the ointment, to obtain a plaster for treating psoriasis; Step 6: cutting and packaging, cutting the prepared medicine patch and packaging it in an aluminum foil packaging bag to obtain a finished medicine patch for treating psoriasis; Step 7: Quality inspection and storage. The finished products of the plaster for treating psoriasis are quality inspected. The quality inspection items include at least the inspection of size, packaging sealing, and the amount of oral and topical medicine. The finished products of the plaster that pass the quality inspection are put into storage.